Reuters logo
BRIEF-Soleno Therapeutics posts Q3 loss $0.24/shr from continuing operations
November 14, 2017 / 1:14 PM / 6 days ago

BRIEF-Soleno Therapeutics posts Q3 loss $0.24/shr from continuing operations

Nov 14 (Reuters) - Soleno Therapeutics Inc

* Soleno Therapeutics provides corporate update and reports third quarter 2017 financial results

* Q3 loss per share $0.24 from continuing operations

* Q3 loss per share $0.35 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below